查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
荐椎神经刺激（SNS）市场规模、份额和成长分析（按产品、应用和地区划分）－产业预测（2026-2033）
市场调查报告书
商品编码
1898084

荐椎神经刺激（SNS）市场规模、份额和成长分析（按产品、应用和地区划分）－产业预测（2026-2033）

Sacral Nerve Stimulation (SNS) Market Size, Share, and Growth Analysis, By Product (Implantable SNS Devices, External SNS Devices), By Application (Urinary and Fecal Incontinence, Chronic Anal Fissure), By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球荐椎神经刺激(SNS) 市场规模预计在 2024 年达到 13.7 亿美元，从 2025 年的 15.6 亿美元增长到 2033 年的 44.6 亿美元，在预测期（2026-2033 年）内复合年增长率为 14%。

荐椎神经刺激（SNS）的全球市场正经历显着成长，这主要受急性尿失禁率上升的推动。尿急症包括尿道感染（UTI）、膀胱过动症（OAB）和粪便失禁等疾病。 SNS 疗法是将一种装置植入荐骨神经，透过精确的电脉衝刺激神经通路，进而影响膀胱控制。此治疗方法已被证实安全有效，尤其适用于对传统治疗方法或药物治疗无效的患者。尿失禁影响相当一部分成年人，尤其是女性，而 SNS 可以帮助改善她们的生活品质。此外，粪便失禁（尤其是在老年族群中）盛行率的不断上升，进一步推动了市场对 SNS 装置的需求，这些装置既能改善患者的生活质量，也能应对社会面临的挑战。

全球荐椎神经刺激（SNS）市场驱动因素

全球荐椎神经刺激（SNS）市场的成长主要受急性尿失禁发病率上升以及膀胱过动症过动症（OAB）和粪便失禁患者数量显着增加的推动。对于那些传统治疗方法或药物治疗效果不佳的患者而言，SNS 已成为有效的治疗选择。随着尿失禁和粪便失禁等功能性疾病的日益普遍，尤其是在老年人中，对 SNS 设备的需求也不断增长。这种需求源自于人们迫切希望改善患者的生活品质、提升膀胱功能并减轻这些症状对日常生活的影响。

限制全球荐椎神经刺激（SNS）市场的因素

全球荐椎神经刺激（SNS）市场面临的一大挑战是SNS设备和治疗程序带来的沉重经济负担。购买和维护这些设备的总成本对患者和医疗保健系统都构成了重大障碍。这不仅包括设备本身的价格，还包括手术介入、后续观察以及潜在併发症的相关费用。此外，医疗保险机构严格的报销政策会加剧患者寻求SNS治疗的困难。这些经济障碍可能会阻碍SNS的广泛应用，并限制市场扩张，特别是在医疗资源和预算有限的地区。

全球荐椎神经刺激（SNS）市场趋势

全球荐椎神经刺激（SNS）市场正经历设备小型化和无线技术融合的变革性趋势。为了满足日益增长的微创治疗需求，製造商正致力于设计小型紧凑的SNS系统，以提高患者的舒适度和便利性。这项发展不仅简化了植入过程，还最大限度地降低了术后併发症的风险，并改善了患者的治疗效果。此外，无线功能的整合实现了更先进的病患监测和远端编程，从而能够制定个人化的治疗方案，并减少患者定期就诊的次数。这与日益增长的个人化医疗解决方案的需求相契合。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 一手和二手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 监管环境
  • 用例

全球荐椎神经刺激（SNS）市场规模（按产品和复合年增长率划分）（2026-2033 年）

  • 嵌入式社群网路设备
  • 外部社交网路设备

全球荐椎神经刺激（SNS）市场规模（按应用及复合年增长率划分）（2026-2033 年）

  • 尿失禁和粪便失禁
  • 慢性肛门裂伤
  • 急性尿失禁
  • 其他的

全球荐椎神经刺激（SNS）市场规模及复合年增长率（2026-2033）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • GCC
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

    主要企业简介

    • 美敦力（美国）
    • NeuroPace公司（美国）
    • 内弗罗公司（美国）
    • 波士顿科学公司（美国）
    • Synapse Biomedical Inc.（美国）
    • 强生公司（美国）
    • 生物医学生命系统公司（美国）
    • Kegel8（Savantini Limited）（英国）
    • EnteroMedics Inc.（美国）
    • LivaNova PLC（英国）
    • Inspire Medical Systems Inc.（美国）
    • 北京平斯医疗有限公司（中国）
    • Saluda Medical Pty Ltd.（澳洲）

结论与建议

简介目录
Product Code: SQMIG35J2066

Global Sacral Nerve Stimulation (SNS) Market size was valued at USD 1.37 Billion in 2024 and is poised to grow from USD 1.56 Billion in 2025 to USD 4.46 Billion by 2033, growing at a CAGR of 14% during the forecast period (2026-2033).

The global market for Sacral Nerve Stimulation (SNS) is witnessing significant growth, driven by the rising occurrence of urge incontinence, including conditions like Urinary Tract Infections (UTI), Overactive Bladder (OAB), and fecal incontinence. SNS entails the implantation of a device that delivers precise electrical impulses to the sacral nerves, thereby influencing neural pathways and bladder control. This treatment is recognized for its safety and efficacy, particularly for patients not benefiting from traditional therapies or medications. A substantial portion of the adult population, especially women, is affected by urinary incontinence, with SNS enhancing their quality of life. Additionally, the increasing prevalence of fecal incontinence, particularly among the elderly, further propels market demand for SNS devices, addressing both quality of life and social challenges faced by individuals.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sacral Nerve Stimulation (SNS) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sacral Nerve Stimulation (SNS) Market Segments Analysis

Global Sacral Nerve Stimulation (SNS) Market is segmented by Product, Application and region. Based on Product, the market is segmented into Implantable SNS Devices and External SNS Devices. Based on Application, the market is segmented into Urinary and Fecal Incontinence, Chronic Anal Fissure, Urge Incontinence and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sacral Nerve Stimulation (SNS) Market

The growth of the global Sacral Nerve Stimulation (SNS) market is largely influenced by the increasing prevalence of urge incontinence, alongside a notable rise in patients experiencing Overactive Bladder (OAB) and fecal incontinence. SNS has emerged as a viable treatment option for individuals who have not found relief through conventional therapy and medication. As urinary and fecal dysfunctions become more common, particularly among the elderly population, there is a heightened demand for SNS devices. This demand is driven by the urgent need to enhance patients' quality of life, improve bladder functionality, and alleviate the impact of these conditions on everyday activities.

Restraints in the Global Sacral Nerve Stimulation (SNS) Market

A notable challenge facing the global Sacral Nerve Stimulation (SNS) market is the substantial financial burden associated with SNS devices and treatment procedures. The overall costs linked to the purchasing and maintenance of these devices present significant obstacles for both patients and healthcare systems. This includes not only the price of the device but also expenses related to surgical interventions, follow-up consultations, and any complications that may arise. Furthermore, restrictive reimbursement policies set by healthcare payers can exacerbate accessibility issues for patients seeking SNS treatment. These financial barriers may hinder widespread adoption and restrict market expansion, especially in areas with limited healthcare resources or budgetary constraints.

Market Trends of the Global Sacral Nerve Stimulation (SNS) Market

The Global Sacral Nerve Stimulation (SNS) market is witnessing a transformative trend towards miniaturization and the incorporation of wireless technology in devices. Manufacturers are increasingly focused on designing smaller, more compact SNS systems that enhance patient comfort and convenience, in response to the rising demand for minimally invasive treatment options. This evolution not only simplifies the implantation process but also minimizes potential post-operative complications, thereby improving patient outcomes. Furthermore, the integration of wireless capabilities facilitates advanced patient monitoring and remote programming, enabling tailored treatment strategies and reducing the necessity for regular clinic visits, which aligns with the growing preference for personalized healthcare solutions.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies

Global Sacral Nerve Stimulation (SNS) Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Implantable SNS Devices
  • External SNS Devices

Global Sacral Nerve Stimulation (SNS) Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Urinary and Fecal Incontinence
  • Chronic Anal Fissure
  • Urge Incontinence
  • Others

Global Sacral Nerve Stimulation (SNS) Market Size & CAGR (2026-2033)

  • North America (Product, Application)
    • US
    • Canada
  • Europe (Product, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuroPace, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nevro Corp. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Synapse Biomedical Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomedical Life Systems Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kegel8 (Savantini Limited) (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EnteroMedics Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inspire Medical Systems Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beijing PINS Medical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Saluda Medical Pty Ltd. (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations